Physician profile
Meltem Ates
NPI 1689087686
$3,851.89
in general payments reported to CMS, 2019-2025
18 companies · $1,586 in 2025
The $1,586 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $14.14 · 2022: $125 · 2023: $188 · 2024: $1,400 · 2025: $1,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,933 · Travel and Lodging: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,932.58 |
| Travel and Lodging | $1,241.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $1,005.02 | 2024 | Truelok |
| Stryker Corporation | $774.34 | 2019-2025 | Citrefix, Flexband, Viaflow |
| Treace Medical Concepts, INC. | $737.85 | 2024-2025 | |
| Integra Lifesciences Corporation | $203.14 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bard Peripheral Vascular, INC. | $201.95 | 2022-2025 | Crosser Iq |
| Cagent Vascular INC | $138.00 | 2025 | Serrantor |
| Angiodynamics, INC. | $128.88 | 2023 | Auryon Laser System 100-120 Vac |
| Wright Medical Technology, INC. | $125.00 | 2019 | |
| Abbott Laboratories | $116.53 | 2024 | Eterna, Proclaim |
| Next Science LLC | $112.30 | 2024-2025 | Xperience, Blastx, Surgx |
| Depuy Synthes Sales INC. | $104.71 | 2019-2024 | |
| Averitas Pharma INC. | $63.68 | 2023-2025 | Qutenza |
| Kerecis Limited | $45.75 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Biowound Solutions, INC. | $23.07 | 2025 | Bio-Connekt |
| Sanara Medtech INC. | $21.17 | 2025 | Biasurge |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $19.37 | 2024 | Apligraf |
| Zimvie INC. | $16.90 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.23 | 2024 | Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meltem Ates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.